1. Home
  2. CHY vs AXGN Comparison

CHY vs AXGN Comparison

Compare CHY & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHY
  • AXGN
  • Stock Information
  • Founded
  • CHY 2003
  • AXGN N/A
  • Country
  • CHY United States
  • AXGN United States
  • Employees
  • CHY N/A
  • AXGN N/A
  • Industry
  • CHY Investment Managers
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CHY Finance
  • AXGN Health Care
  • Exchange
  • CHY Nasdaq
  • AXGN Nasdaq
  • Market Cap
  • CHY 934.9M
  • AXGN 813.6M
  • IPO Year
  • CHY N/A
  • AXGN N/A
  • Fundamental
  • Price
  • CHY $11.54
  • AXGN $18.97
  • Analyst Decision
  • CHY
  • AXGN Strong Buy
  • Analyst Count
  • CHY 0
  • AXGN 4
  • Target Price
  • CHY N/A
  • AXGN $15.00
  • AVG Volume (30 Days)
  • CHY 128.3K
  • AXGN 607.5K
  • Earning Date
  • CHY 01-01-0001
  • AXGN 03-04-2025
  • Dividend Yield
  • CHY 10.11%
  • AXGN N/A
  • EPS Growth
  • CHY N/A
  • AXGN N/A
  • EPS
  • CHY N/A
  • AXGN N/A
  • Revenue
  • CHY N/A
  • AXGN $180,855,000.00
  • Revenue This Year
  • CHY N/A
  • AXGN $18.91
  • Revenue Next Year
  • CHY N/A
  • AXGN $13.02
  • P/E Ratio
  • CHY N/A
  • AXGN N/A
  • Revenue Growth
  • CHY N/A
  • AXGN 18.79
  • 52 Week Low
  • CHY $9.97
  • AXGN $5.55
  • 52 Week High
  • CHY $12.16
  • AXGN $18.99
  • Technical
  • Relative Strength Index (RSI)
  • CHY 34.53
  • AXGN 67.82
  • Support Level
  • CHY $11.58
  • AXGN $18.02
  • Resistance Level
  • CHY $11.85
  • AXGN $18.96
  • Average True Range (ATR)
  • CHY 0.22
  • AXGN 1.21
  • MACD
  • CHY -0.03
  • AXGN 0.20
  • Stochastic Oscillator
  • CHY 10.68
  • AXGN 99.40

About CHY Calamos Convertible and High Income Fund

Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high yield securities.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Share on Social Networks: